Physiological pharmacokinetic model for pentazocine. I. Tissue distribution and elimination in the rat
- 31 July 1983
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 15 (3), 321-333
- https://doi.org/10.1016/0378-5173(83)90165-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic modelsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Pharmacokinetics of pentazocine in dogs under halothane anesthesia.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- Bioavailability and first‐pass metabolism of oral pentazocine in manClinical Pharmacology & Therapeutics, 1977
- Generalized consideration of administration route dependence of drug disposition and use of urinary data for prediction of the dependence.CHEMICAL & PHARMACEUTICAL BULLETIN, 1976
- Lidocaine disposition kinetics in monkey and man; I. Prediction by a perfusion modelCancer Cell, 1974
- Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentographyJournal of Pharmacy and Pharmacology, 1974
- Transport and Binding of Methotrexate In VivoJournal of Pharmaceutical Sciences, 1973
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971
- Thiopental PharmacokineticsJournal of Pharmaceutical Sciences, 1968
- Differential distribution of pentazocine-3H and cis-3-chloroallylnorpentazocine-3H in the catToxicology and Applied Pharmacology, 1968